...
机译:以可开发性为重点的优化方法可以鉴定体内速效抗疟药:N-3-(苯并咪唑-2-基)氨基丙基酰胺
Univ Helsinki, Div Pharmaceut Chem & Technol, Fac Pharm, FI-00014 Helsinki, Finland;
GlaxoSmithKline, Tres Cantos Med Dev Campus, Madrid 28760, Spain;
机译:Optimization of 2-Anilino 4-Amino Substituted Quinazolines into Potent Antimalarial Agents with Oral in Vivo Activity
机译:Pharmacomodulation on the 3-acetylursolic acid skeleton: Design, synthesis, and biological evaluation of novel N-{3-(4-(3-aminopropyl)piperazinyl)propyl}-3-O-acetylursolamide derivatives as antimalarial agents.
机译:Identification of 1,3-(Dimethyl/Propyl)-8-Susbtituted (Cinnamic acid/Furan) Xanthine Derivatives with Anti-bronchospasmodic Activity Using in silico and in vivo Techniques
机译:N-(2-氯苯甲酰基)-3-硝基苯amide磺酰胺
机译:(S)-2-[(3S,8S,9S,10R,13S,14S,-17R)-3-羟基-10,13-二甲基-2,3,4,7,8,9,10的晶体结构,11,12,13,14,15,16,17-十四氢-1H-环戊-[a]菲基-17-基] -N-甲氧基-N-甲基丙酰胺(Fernholz Weinreb amide)